Fundraising FoxParadigm Therapeutics
Mt Pleasant, US · 1 known investors
Find your way into Paradigm Therapeutics
Sign up to see every warm intro you have to Paradigm Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paradigm Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paradigm Therapeutics is a biopharmaceutical company developing Zorblesia (SD-101), a proprietary topical whole-body therapy for treating the wounds, lesions, and infections associated with all subtypes of Epidermolysis Bullosa (EB), a rare genetic connective tissue disorder. The company focuses on discovering and delivering therapies for patients with serious, life-threatening diseases.
Founders & leadership
RR
Robert RyanDr.
Investors · 1
In the news
Frequently asked questions
- What does Paradigm Therapeutics do?
- Paradigm Therapeutics is a biopharmaceutical company developing Zorblesia (SD-101), a proprietary topical whole-body therapy for treating the wounds, lesions, and infections associated with all subtypes of Epidermolysis Bullosa (EB), a rare genetic connective tissue disorder. The company focuses on discovering and delivering therapies for patients with serious, life-threatening diseases.
- Who are Paradigm Therapeutics's investors?
- Paradigm Therapeutics's investors include Eshelman Ventures, LLC.
- Where is Paradigm Therapeutics headquartered?
- Paradigm Therapeutics is headquartered in Mt Pleasant, US.